Literature DB >> 9464932

Csk and BatK show opposite temporal expression in the rat CNS: consistent with its late expression in development, BatK induces differentiation of PC12 cells.

S S Kuo1, M P Armanini, H S Phillips, I W Caras.   

Abstract

BatK is a second member of the Csk family of regulatory kinases that phosphorylate a key inhibitory tyrosine on Src family kinases, leading to down-regulation. To investigate the roles of BatK and Csk, both of which are expressed in the brain, we compared their temporal expression patterns during development of the central nervous system (CNS) in rats. BatK mRNA is undetectable at embryonic day 12 (E12), appears in the developing nervous system at approximately E15, and its expression progressively increases up to the time of birth, thereafter remaining high throughout the adult brain. In striking contrast, Csk is highly expressed throughout embryonic development and remains high in the CNS until birth. It is then dramatically down-regulated in the adult brain except in the olfactory bulb. BatK and Csk thus exhibit complementary temporal expression patterns. Since BatK expression correlates with late-stage development and terminal differentiation, we speculated that it might be involved in regulating neuronal differentiation. Using PC12 cells as a model system, we show that overexpression of BatK is sufficient to induce neurite outgrowth in the absence of nerve growth factor. Further, overexpression of BatK activates the mitogen-activated protein kinase cascade. We propose a model suggesting that, despite overlapping in vitro activities, BatK and Csk regulate different targets in vivo and have different functions during and after neuronal development, BatK being the dominant regulator of Src kinases in the fully differentiated adult brain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9464932     DOI: 10.1111/j.1460-9568.1997.tb01655.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  5 in total

1.  IGF-I stimulates cooperative interaction between the IGF-I receptor and CSK homologous kinase that regulates SHPS-1 phosphorylation in vascular smooth muscle cells.

Authors:  Yashwanth Radhakrishnan; Xinchun Shen; Laura A Maile; Gang Xi; David R Clemmons
Journal:  Mol Endocrinol       Date:  2011-07-28

2.  Defining the substrate specificity determinants recognized by the active site of C-terminal Src kinase-homologous kinase (CHK) and identification of β-synuclein as a potential CHK physiological substrate.

Authors:  Kim K Ia; Grace R Jeschke; Yang Deng; Mohd Aizuddin Kamaruddin; Nicholas A Williamson; Denis B Scanlon; Janetta G Culvenor; Mohammed Iqbal Hossain; Anthony W Purcell; Sheng Liu; Hong-Jian Zhu; Bruno Catimel; Benjamin E Turk; Heung-Chin Cheng
Journal:  Biochemistry       Date:  2011-07-18       Impact factor: 3.162

3.  Control of excitatory synaptic transmission by C-terminal Src kinase.

Authors:  Jindong Xu; Manjula Weerapura; Mohammad K Ali; Michael F Jackson; Hongbin Li; Gang Lei; Sheng Xue; Chun L Kwan; Morris F Manolson; Kai Yang; John F Macdonald; Xian-Min Yu
Journal:  J Biol Chem       Date:  2008-04-29       Impact factor: 5.157

4.  Phosphoprotein associated with glycosphingolipid-enriched microdomains differentially modulates SRC kinase activity in brain maturation.

Authors:  Sabine Lindquist; Diana Karitkina; Kristina Langnaese; Anita Posevitz-Fejfar; Burkhart Schraven; Ramnik Xavier; Brian Seed; Jonathan A Lindquist
Journal:  PLoS One       Date:  2011-09-06       Impact factor: 3.240

5.  Disruption of Src Is Associated with Phenotypes Related to Williams-Beuren Syndrome and Altered Cellular Localization of TFII-I

Authors:  Laleh Sinai; Evgueni A Ivakine; Emily Lam; Marielle Deurloo; Joana Dida; Ralph A Zirngibl; Cynthia Jung; Jane E Aubin; Zhong-Ping Feng; John Yeomans; Roderick R McInnes; Lucy R Osborne; John C Roder
Journal:  eNeuro       Date:  2015-03-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.